[Earlier value assessment of pharmaceutical products and medical science]

Nervenarzt. 2016 Apr;87(4):353-5. doi: 10.1007/s00115-016-0103-3.

[Article in German]

Author

Affiliation

¹ Institut für Medizinische Informationsverarbeitung, Universität Tübingen, Panoramastr. 22, 72414, Rangendingen, Deutschland. [email protected].

PMID: 27000270
DOI: 10.1007/s00115-016-0103-3

No abstract available

Publication types

Editorial

MeSH terms

Drug Approval / economics
Drug Approval / legislation & jurisprudence*
Drug Industry / legislation & jurisprudence*
Endpoint Determination / standards
Germany
Government Regulation
Health Care Reform / economics
Health Care Reform / legislation & jurisprudence
Legislation, Drug*
Marketing of Health Services / economics
Marketing of Health Services / legislation & jurisprudence
Outcome Assessment, Health Care / economics
Outcome Assessment, Health Care / legislation & jurisprudence*
Outcome Assessment, Health Care / methods*
Quality Assurance, Health Care / economics
Quality Assurance, Health Care / legislation & jurisprudence*
Risk Assessment